Clinical Trial

Observation of Clozapine Treatment Safety in Bipolar Disorder.

Study acronym: CloGD
Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated August 25, 2023 (before its estimated December 31, 2024 completion). Its status may not reflect the trial's current state.
Summary
The purpose of the registry is to record incidence of adverse events during treatment with clozapine in patients suffering from bipolar disorder.
Trial Details
NCT Number NCT06011460
Lead Sponsor Medical University of Gdansk
Conditions Bipolar Disorder
Enrollment 30 participants
Start Date 2023-02-23
Primary Completion 2024-12-31 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2023-08-25